Novo Nordisk A/S
- News
‘Miracle’ drug innovation could see a new Wegovy launch every couple of years, Larry Summers says
Larry Summers, president emeritus and professor at Harvard University, at the World Economic Forum (WEF) in Davos, Switzerland, on Tuesday,…
Read More » - News
GLP-1s and Brian Thompson’s killing loom large at top health-care conference
Jamie Dimon, chief executive officer of JPMorgan Chase & Co., at the Institute of International Finance (IIF) during the annual…
Read More » - News
Eli Lilly shares drop as drugmaker cuts revenue guidance on weight loss drug demand
The Eli Lilly & Co. logo at the company’s Digital Health Innovation Hub facility in Singapore, on Thursday, Nov. 14,…
Read More » - U.S. News
FDA says the Zepbound shortage is over. Here’s what that means for compounding pharmacies, patients who used off-brand versions
An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City on Dec. 11, 2023.…
Read More » - U.S. News
Digital health companies got pummeled by Wall Street in 2024 as industry adapts to post-Covid slowdown
Doximity at the New York Stock Exchange for their IPO, June 24, 2021. Source: NYSE If the Covid era marked…
Read More » - Europe
European markets open higher in shortened session ahead of Christmas; Novo Nordisk resumes recovery
The entrance of the London Stock Exchange Group building on Dec. 8, 2024. Manuel Romano | Nurphoto | Getty Images…
Read More » - News
CNBC Daily Open: Inflation and dot plots
A person shops at a Whole Foods Market grocery store on December 17, 2024 in New York City. Spencer Platt…
Read More » - News
CNBC Daily Open: With cooler-than-expected PCE, would the Fed’s dot plot have looked different?
A customer, holding a carton of eggs at a supermarket, in United States on Dec. 20, 2024. Secuk Ancar |…
Read More »